Aptamer Group PLC (AIM:APTA)
London
· Delayed Price · Currency is GBP · Price in GBX 0.6850
+0.0350 (5.38%)
Aug 15, 2025, 4:35 PM GMT+1
Aptamer Group Market Cap
Aptamer Group has a market cap or net worth of 18.23 million as of August 15, 2025. Its market cap has increased by 1,559.69% in one year.
Market Cap
18.23M
Enterprise Value
16.90M
Revenue
1.22M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.69
Market Cap Chart
Since December 22, 2021, Aptamer Group's market cap has decreased from 97.55M to 18.23M, a decrease of -81.31%. That is a compound annual growth rate of -36.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 18.23M | 156.54% |
| Dec 31, 2024 | 7.11M | 32.20% |
| Dec 29, 2023 | 5.37M | -84.73% |
| Dec 30, 2022 | 35.20M | -62.04% |
| Dec 31, 2021 | 92.73M | -4.95% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 177.46B |
| GSK plc | 57.85B |
| Haleon | 32.21B |
| Smith & Nephew | 11.81B |
| ConvaTec Group | 4.73B |
| Hikma Pharmaceuticals | 3.96B |
| Oxford Nanopore Technologies | 2.11B |
| HUTCHMED (China) | 2.02B |